Avidity Partners Management LP
- SEC CIK
- 0001791827
- Latest filing
- Aug 14, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 28, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 45
- +6 vs. Q4 2025
- Portfolio value
- $493.8M
- +$147.1M (+42.4%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DNTHDianthus Therapeutics, Inc. | COM | 2,104,184 | $176.6M | 35.8% | 00.0% | Unchanged | History |
| CGONCG Oncology, Inc. | COM | 1,288,948 | $87.2M | 17.7% | −183,751−12.5% | Reduced | History |
| ORKAOruka Therapeutics, Inc. | COM | 760,424 | $37.3M | 7.6% | +100,000+15.1% | Added | History |
| CATXPerspective Therapeutics, Inc. | COM NEW | 6,049,999 | $25.2M | 5.1% | +2,839,266+88.4% | Added | History |
| JBIOJade Biosciences, Inc. | COM NEW | 1,400,708 | $19.7M | 4.0% | 00.0% | Unchanged | History |
| ELVNEnliven Therapeutics, Inc. | COM | 400,000 | $15.7M | 3.2% | +259,700+185.1% | Added | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 450,100 | $13.6M | 2.7% | +32,800+7.9% | Added | History |
| CNTXContext Therapeutics Inc. | COM | 4,998,267 | $13.1M | 2.7% | −506,588−9.2% | Reduced | History |
| RGENRepligen Corp | COM | 77,800 | $9.17M | 1.9% | +27,500+54.7% | Added | History |
| PVLAPalvella Therapeutics, Inc. | COM | 70,000 | $8.73M | 1.8% | +50,700+262.7% | Added | History |
| MDTMedtronic plc | Stock | 100,000 | $8.66M | 1.8% | −7,600−7.1% | Reduced | History |
| VIRVir Biotechnology, Inc. | COM | 950,000 | $8.51M | 1.7% | +950,000 | New | History |
| AKTSAktis Oncology, Inc. | COM | 468,566 | $8.38M | 1.7% | +468,566 | New | History |
| IMUXImmunic, Inc. | COM | 6,699,411 | $7.44M | 1.5% | +2,000,000+42.6% | Added | History |
| DXCMDexcom Inc | COM | 90,000 | $5.65M | 1.1% | +90,000 | New | History |
| EHCEncompass Health Corp | COM | 42,000 | $4.06M | 0.8% | +10,400+32.9% | Added | History |
| BSXBoston Scientific Corp | Stock | 60,000 | $3.77M | 0.8% | −54,500−47.6% | Reduced | History |
| TENXTenax Therapeutics, Inc. | COM NEW | 215,934 | $3.45M | 0.7% | +215,934 | New | History |
| GILDGilead Sciences, Inc. | Stock | 20,000 | $2.79M | 0.6% | +20,000 | New | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 249,390 | $2.77M | 0.6% | +43,314+21.0% | Added | History |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 463,741 | $2.58M | 0.5% | +329,175+244.6% | Added | History |
| CNCCentene Corp | Stock | 70,000 | $2.29M | 0.5% | −49,400−41.4% | Reduced | History |
| MSLESatellos Bioscience Inc. | COM | 387,769 | $2.18M | 0.4% | +387,769 | New | History |
| SCYXScynexis Inc | COM NEW | 2,081,660 | $1.91M | 0.4% | 00.0% | Unchanged | History |
| NTRANatera, Inc. | COM | 9,000 | $1.80M | 0.4% | −2,800−23.7% | Reduced | History |
| ICLRIcon PLC | COM | 16,000 | $1.77M | 0.4% | −17,100−51.7% | Reduced | History |
| KVUEKenvue Inc. | Stock | 100,000 | $1.72M | 0.3% | −132,800−57.0% | Reduced | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 115,000 | $1.68M | 0.3% | +115,000 | New | History |
| HIMSHims & Hers Health, Inc. | Stock | 75,000 | $1.56M | 0.3% | +75,000 | New | History |
| RVMDRevolution Medicines, Inc. | COM | 15,000 | $1.46M | 0.3% | +15,000 | New | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 30,000 | $1.45M | 0.3% | +30,000 | New | History |
| GMABGenmab A/S | SPONSORED ADS | 50,000 | $1.34M | 0.3% | −42,000−45.7% | Reduced | History |
| CORTCorcept Therapeutics Inc | COM | 30,000 | $1.21M | 0.2% | +8,000+36.4% | Added | History |
| TEMTempus AI, Inc. | CL A | 25,000 | $1.13M | 0.2% | +25,000 | New | History |
| ABVXAbivax S.A. | SPONSORED ADS | 10,000 | $1.11M | 0.2% | +10,000 | New | History |
| UNHUnitedHealth Group Inc | Stock | 3,800 | $1.03M | 0.2% | +3,800 | New | History |
| NTLAIntellia Therapeutics, Inc. | COM | 75,000 | $961.5K | 0.2% | +75,000 | New | History |
| ODDOddity Tech Ltd | SHS CL A | 70,000 | $936.6K | 0.2% | +70,000 | New | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 50,000 | $932.0K | 0.2% | +50,000 | New | History |
| PTONPeloton Interactive, Inc. | CL A COM | 200,000 | $858.0K | 0.2% | +200,000 | New | History |
| AVRAnteris Technologies Global Corp. | COM | 150,000 | $832.5K | 0.2% | +150,000 | New | History |
| ABUSArbutus Biopharma Corp | COM | 125,000 | $562.5K | 0.1% | +125,000 | New | History |
| BBOTBridgeBio Oncology Therapeutics, Inc. | COM NEW | 43,853 | $392.5K | 0.1% | +43,853 | New | History |
| ACADAcadia Pharmaceuticals Inc | COM | 12,967 | $288.6K | 0.1% | −93,933−87.9% | Reduced | History |
| TRVITrevi Therapeutics, Inc. | COM | 6,660 | $79.5K | <0.1% | +6,660 | New | History |
Sold out since Q4 2025 (15)
Positions held at the end of Q4 2025 that are gone from this filing.
| Security | Class | Shares in Q4 2025 | Value in Q4 2025 | % of portfolio in Q4 2025 | History |
|---|---|---|---|---|---|
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 21,000 | $8.35M | 2.4% | History |
| MCKMcKesson Corp | Stock | 9,520 | $7.81M | 2.3% | History |
| AAgilent Technologies, Inc. | COM | 41,500 | $5.65M | 1.6% | History |
| PFEPfizer Inc | Stock | 203,600 | $5.07M | 1.5% | History |
| DHRDanaher Corp | Stock | 17,000 | $3.89M | 1.1% | History |
| TMOThermo Fisher Scientific Inc. | Stock | 6,700 | $3.88M | 1.1% | History |
| NVONovo Nordisk A S | ADR | 67,300 | $3.42M | 1.0% | History |
| CICigna Group | Stock | 11,600 | $3.19M | 0.9% | History |
| CORCencora, Inc. | Stock | 9,400 | $3.17M | 0.9% | History |
| INSMINSMED Inc | COM PAR $.01 | 17,700 | $3.08M | 0.9% | History |
| WATWaters Corp | COM | 8,100 | $3.08M | 0.9% | History |
| ACHCAcadia Healthcare Company, Inc. | COM | 169,000 | $2.40M | 0.7% | History |
| ITGRInteger Holdings Corp | COM | 29,800 | $2.34M | 0.7% | History |
| HQYHealthequity, Inc. | COM | 16,900 | $1.55M | 0.4% | History |
| IQVIQVIA Holdings Inc. | Stock | 4,400 | $991.8K | 0.3% | History |